From the HSLDA E-lert Service:


2/27/2007 5:38:34 PM
Home School Legal Defense Association
Colorado: Bill Requires New Immunization Reporting For Pre-Teen Girls

From the HSLDA E-lert Service...

February 27, 2007

Colorado: Bill Requires New Immunization Reporting For Pre-Teen Girls

Dear HSLDA members and friends,

The Colorado Legislature is considering a bill that would require all
female students over the age of 12 to receive information about the
link between human papillomavirus (HPV) and cervical cancer, and the
availability of the HPV vaccine. These girls would then have to
present evidence that they have been immunized against four types of
the human papillomavirus (HPV) that are mainly transmitted by sexual
contact or evidence that the parent has elected for the girl to not
receive the vaccine.

Immunizing young girls with a vaccine that is being questioned by
doctors about its lack of effectiveness should not be paid for by
taxpayer dollars. Even the pharmaceutical company, Merck, is no longer
lobbying for these bills, such as S.B. 80, because of the short-term
effectiveness of this vaccine.

Senate Bill 80 has passed the Senate Committee on Health and Human
Services and has been sent to the Senate Appropriations Committee for
a hearing on Friday, March 2, at 7:30 a.m., Room SCR 356. The
Appropriations Committee will only address cost and funding issues. If
it passes the Appropriations Committee, it will be heard by the full

We are working with Treon Goossen with Concerned Parents of Colorado
to oppose this bill.


Please contact the members of the Senate Appropriations Committee and
give them this message in your own words:

"Please oppose Senate Bill 80 which mandates that virtually all young
girls to be immunized against HPV. Immunizing young girls with a
vaccine that is being questioned by doctors about its lack of
effectiveness should not be paid for by taxpayer dollars. Even the
pharmaceutical company, Merck, is no longer lobbying for these bills,
such as S.B. 80, because of the short-term effectiveness of this

Please do not identify yourself as a homeschooler but instead can call
as a concerned parent and constituent.

Senate Appropriations Committee:

Chair: Senator Abel Tapia (D)

Vice Chair: Senator Maryanne (Moe) Keller, (D)

Greg Brophy, (R) 303-866-6360
Peter Groff, (D) 303-866-4864
Ted Harvey, (R) 303-866-4881
Steve Johnson, (R) 303-866-4853
Mike Kopp, (R) 303-866-4859
Stephanie Takis, (D) 303-866-4855


Human papillomavirus, or HPV, is a group of viruses that have about
100 different strains or types. Over 30 of these viruses are sexually
transmitted. While most HPV infections are dealt with by the body's
immune system and no symptoms occur, there are several types that can
cause cervical cancer or genital warts. For more information about HPV
see the Center for Disease Control and Prevention information here: .

Those who are most likely to get HPV are those who have sex at an
early age, have many sex partners, or have a sex partner who has had
many partners.

However, the only FDA approved HPV vaccine, Gardasil,
( ) is not a cure for HPV or cervical cancer.
Instead the vaccine seeks to prevent the four specific types of HPV
(6, 11, 16, and 18) which are responsible for 70% of cervical cancers
and 90% of genital warts. There is currently no cure for these
sexually transmitted viruses. Even the FDA and the CDE admit the only
"cure" is abstinence before marriage and a monogamous relationship
during marriage.

There have been no long-term studies of the HPV vaccine. Children in
the 9-year-old age group have been monitored for only 18 months and
there have been no studies on the carcinogenic risk or the general
toxicity of the vaccine itself. From July 2006 to the end of 2006,
there were 385 unique reports of adverse events filed with the Vaccine
Adverse Event Reporting System (VAERS) following the receipt of the
vaccine. For a full review of these reports please see .

Additionally, there is some concern that rushing to mandate the HPV
vaccine for pre-teen girls will not have the intended affect of
preventing cervical cancer. Early immunization may not be effective
because the vaccine could wear off before the person is most
susceptible. Gardasil has only been proven to have a 5 years of proven
effectiveness. While there appears to be a 10-to-15-year incubation
period for certain HPV types potentially becoming cervical cancer, the
average age a woman contracts cervical cancer is in her mid 40s. For
more information see .

Over the past few months, Merck, the pharmaceutical manufacturer of
Gardasil, has lobbied vigorously to mandate the HPV vaccine for middle
school age girls. At present there are over 34 states where HPV bills
have been introduced. Several state legislatures have defeated

Due to all of the concerns raised about mandating the Gardasil vaccine
to middle school age girls Merck has abandoned its efforts to lobby
state legislatures to require the vaccine.

Thank you for your time to make the call on behalf of freedom of
private schools in Colorado.


Christopher J. Klicka
HSLDA Senior Counsel

-> What's the shortest distance between two homeschoolers?

HSLDA's elert service! When threats to homeschool freedoms arise,
you want to be able to respond. We make it possible.

More reasons to join HSLDA...

The HSLDA E-lert Service is a service of:

Home School Legal Defense Association
P.O. Box 3000
Purcellville, Virginia 20134
Phone: (540) 338-5600
Fax: (540) 338-2733

How To Subscribe:

- Subscribe to the HSLDA E-lert Service at our website:

- Or send an email with name and complete mailing address to:

Subscription Information:

- You subscribed to the HSLDA E-lert Service as:


- To unsubscribe from the HSLDA E-lert Service send an email from
the email address you want to unsubscribe to:

- To change your email address or make other changes to your
subscription, visit the HSLDA E-lert Service account web page at:

POSTMASTERS: This message is being sent to the most recent address we
have for our subscribers. If this is an invalid email address or you
have other problems, please reply to
DISCLAIMER: This is considered a private and confidential message
from HSLDA to its bonafide HSLDA E-lert Service subscribers.
HSLDA cannot attest to the authenticity of copies posted, forwarded,
or sent by any party other than HSLDA.
NOTE: Please do not reply or otherwise use this email address; is for broadcast purposes only and is not intended to
receive incoming messages. We cannot reply to any email sent to this
address. If you have comments or questions, please send email to or call HSLDA at 540-338-5600. HSLDA members can also
email staff directly through the Members website at Thank you for your cooperation.